Spots Global Cancer Trial Database for shr6390 tablets
Every month we try and update this database with for shr6390 tablets cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer | NCT03966898 | Advanced Breast... | SHR6390 Tablets Placebo Tablets Letrozole or An... | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer | NCT03966898 | Advanced Breast... | SHR6390 Tablets Placebo Tablets Letrozole or An... | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
